Treatment of glaucoma and ocular hypertension with .beta.3-adren

Details Treatment of glaucoma and ocular hypertension with .beta.3-adren Treatment of glaucoma and ocular hypertension with .beta.3-adren

1993-11-05

1996-10-08

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3136

Patent

active

055631711

ABSTRACT:
Substituted 5-2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles having the structural formula: ##STR1## wherein R4, R5, R6, R7, and R8 are as hereinafter defined, are .beta.3-adrenergic agonists useful in the treatment of elevated intraocular pressure and glaucoma.

REFERENCES:
patent: 4309443 (1982-01-01), Smith et al.
patent: 4329358 (1982-05-01), Ainsworth et al.
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4341793 (1982-07-01), Ferris
patent: 4382958 (1983-05-01), Duckworth
patent: 4385066 (1983-05-01), Ainsworth et al.
patent: 4391826 (1983-07-01), Mills et al.
patent: 4432993 (1984-02-01), Ferris
patent: 4568691 (1986-02-01), Marsham et al.
patent: 4585796 (1986-04-01), Alig et al.
patent: 4588749 (1986-05-01), Ferris
patent: 4593023 (1986-06-01), Hindley
patent: 4596800 (1986-06-01), Ainsworth et al.
patent: 4602044 (1986-07-01), Schmiegel et al.
patent: 4622342 (1986-11-01), Cantello et al.
patent: 4629737 (1986-12-01), Cantello
patent: 4652679 (1987-03-01), Alig et al.
patent: 4654371 (1987-03-01), Ainsworth et al.
patent: 4683312 (1987-07-01), Dominianni et al.
patent: 4692465 (1987-09-01), Hindley et al.
patent: 4695580 (1987-09-01), Ohashi et al.
patent: 4707497 (1987-11-01), Cecchi et al.
patent: 4772631 (1988-09-01), Holloway et al.
patent: 4783460 (1988-11-01), Cantello
patent: 4803293 (1989-02-01), Berge et al.
patent: 4871755 (1989-10-01), Alig et al.
patent: 4892886 (1990-01-01), Alig et al.
patent: 4927836 (1990-05-01), Holloway et al.
patent: 4977148 (1990-12-01), Holloway et al.
patent: 4992473 (1991-02-01), Anderson et al.
patent: 4999377 (1991-03-01), Caulkett et al.
patent: 5017619 (1991-05-01), Alig et al.
patent: 5045567 (1991-09-01), Kienzie
patent: 5061727 (1991-10-01), Bloom et al.
patent: 5106867 (1992-04-01), Bloom et al.
patent: 5153210 (1992-10-01), Ainsworth et al.
patent: 5166218 (1992-11-01), Alig et al.
patent: 5202466 (1993-04-01), Boigegrain et al.
Investigative Ophthalmology, pp. 455-457, Jun. 1974.
Pharmacological Basis of Therapeutics, Goodman & Gilman, Chapter 9, McMillan Publishing, NY 1980 (6th Ed.).
E.J. of Pharmacol., 100 (1984), 309-319.
Nature, vol. 309, pp. 163-165 (1984).
Current Eye Research, vol. 4, No. 7, pp. 775-780 (1985).
Brit. J. Pharmacol., 100:831-839 (1990).
Science, 245:1118-1121 (1989).
Potter et al, Curr. Eye Res., (1983), 2(10), 711-19.

Affiliated with

Also associated with

Rating

Treatment of glaucoma and ocular hypertension with .beta.3-adren does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of glaucoma and ocular hypertension with .beta.3-adren, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of glaucoma and ocular hypertension with .beta.3-adren will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-57786